Despite considerable progress towards our understanding of the signaling pathways leading to resveratrol-mediated apoptosis, the molecular mechanisms by which resveratrol sensitizes prostate cancer cells to TRAIL treatment is not fully understood. The gene discussed is TNFSF10; the disease is prostate carcinoma.